null

SMILES: CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O

InChI Key: InChIKey=PVKYTTHZBVOPMK-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 50458615   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Group 10 secretory phospholipase A2 (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	170	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair
Phospholipase A2, membrane associated (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	170	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair
Phospholipase A2 group V (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of sPLA2-5 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substra...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair
Group 10 secretory phospholipase A2 (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	330	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of recombinant human sPLA2-10 using human HDL as substrate pretreated for 20 mins followed by substrate addition and measured after 60 min...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair
Group 10 secretory phospholipase A2 (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	170	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair
Phospholipase A2, membrane associated (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	170	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair
Phospholipase A2 group V (Homo sapiens (Human))	BDBM50458615 (CHEMBL4203027) Show SMILES CCC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H18F3N3O4/c1-2-11(19(28)29)8-13-4-3-5-17(25-13)26-15-10-14(30-20(21,22)23)7-6-12(15)9-16(26)18(24)27/h3-7,9-11H,2,8H2,1H3,(H2,24,27)(H,28,29)	KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca Curated by ChEMBL					Assay Description Inhibition of sPLA2-5 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substra...				ACS Med Chem Lett 9: 600-605 (2018) Article DOI: 10.1021/acsmedchemlett.7b00507 BindingDB Entry DOI: 10.7270/Q2Z32272
					More data for this Ligand-Target Pair